Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MesenFlow Technologies is a Swiss preclinical biotechnology company that provides a proprietary bio-imaging platform designed to accelerate drug development and cosmetic testing. By utilizing advanced microscopy, physiological flow simulation, and AI-powered analysis, the company's platform recreates human tissue-based models of inflammation and disease to track immune cell behavior in real time. This technology allows researchers to evaluate compound safety, efficacy, and mechanism of action early in the development process, offering a human-relevant alternative that reduces reliance on animal testing. MesenFlow's solutions are applied across various fields, including oncology, inflammation, toxicology, cosmetics, and nutrition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MesenFlow Technologies.